Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PTGX

Protagonist Therapeutics Inc

May 05 • 04:00PM ET

99.21

-0.31 -0.31 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AMGN REGN CRSP VRTX NTLA BLUE ARWR EDIT AKRO SGMO

| Held by: IJR VTI VB IWM XBI VBK VXF SPSM IJT IWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.04	Insider Own	5.79%	Shs Outstand	62.58M	Perf Week	-1.98%
Market Cap	6.35B	Forward P/E	-	EPS next Y	-0.82	Insider Trans	-8.22%	Shs Float	60.12M	Perf Month	-3.58%
Enterprise Value	5.79B	PEG	-	EPS next Q	1.81	Inst Own	113.59%	Short Float	13.97%	Perf Quarter	15.91%
Income	-130.15M	P/S	137.99	EPS this Y	263.12%	Inst Trans	2.51%	Short Ratio	11.46	Perf Half Y	26.19%
Sales	46.02M	P/B	10.10	EPS next Y	-124.62%	ROA	-18.37%	Short Interest	8.40M	Perf YTD	13.59%
Book/sh	9.82	P/C	11.19	EPS next 5Y	-	ROE	-20.18%	52W High	107.84 -8.00%	Perf Year	124.05%
Cash/sh	8.86	P/FCF	113.24	EPS past 3/5Y	7.63% -1.26%	ROIC	-20.90%	52W Low	41.28 140.31%	Perf 3Y	299.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.07% 9.96%	Gross Margin	97.22%	Volatility	2.91% 3.95%	Perf 5Y	240.93%
Dividend TTM	-	EV/Sales	125.88	EPS Y/Y TTM	-145.57%	Oper. Margin	-343.63%	ATR (14)	4.00	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.71	Sales Y/Y TTM	-89.41%	Profit Margin	-282.83%	RSI (14)	47.19	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	12.71	EPS Q/Q	-134.96%	SMA20	-2.56%	Beta	1.89	Target Price	114.85
Payout	-	Debt/Eq	0.02	Sales Q/Q	-95.64%	SMA50	0.24%	Rel Volume	0.53	Prev Close	99.52
Employees	132	LT Debt/Eq	0.01	Earnings	May 05 AMC	SMA200	23.71%	Avg Volume	732.56K	Price	99.21
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	109.99% 381.68%	Trades		Volume	398,043	Change	-0.31%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)